• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物信息学分析提示 STAT5A 是低分化侵袭性乳腺癌中 miR-650 的靶基因。

A Bioinformatic Pipeline Places STAT5A as a miR-650 Target in Poorly Differentiated Aggressive Breast Cancer.

机构信息

M. Sc. Program in Biochemical Science, National Autonomous University of Mexico, 04510 Mexico City, Mexico.

Research Unit in Virology and Cancer, Children's Hospital of Mexico Federico Gómez, 06720 Mexico City, Mexico.

出版信息

Int J Mol Sci. 2020 Oct 19;21(20):7720. doi: 10.3390/ijms21207720.

DOI:10.3390/ijms21207720
PMID:33086498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7589888/
Abstract

Breast cancer (BRCA) is a leading cause of mortality among women. Tumors often acquire aggressive features through genomic aberrations affecting cellular programs, e.g., the epithelial to mesenchymal transition (EMT). EMT facilitates metastasis leading to poor prognosis. We previously observed a correlation between an amplification of miR-650 (Amp-650) and EMT features in BRCA samples isolated from Mexican patients. In this study, we explored the cBioportal database aiming to extend that observation and better understand the importance of Amp-650 for BRCA aggressiveness. We found that Amp-650 is more frequent in aggressive molecular subtypes of BRCA, as well as in high grade poorly differentiated tumors, which we confirmed in an external miRNA expression database. We performed differential expression analysis on samples harboring Amp-650, taking advantage of gene target prediction tools and tumor suppressor gene databases to mine several hundreds of differentially underexpressed genes. We observed STAT5A as a likely putative target gene for miR-650 in aggressive poorly differentiated BRCA. Samples with both Amp-650 and low expression of STAT5A had less overall survival than samples with either or none of the alterations. No target gene has been described for miR-650 in BRCA, thus, this bioinformatic study provides valuable information that should be corroborated experimentally.

摘要

乳腺癌(BRCA)是女性死亡的主要原因之一。肿瘤经常通过影响细胞程序的基因组异常获得侵袭性特征,例如上皮到间充质转化(EMT)。EMT 促进转移,导致预后不良。我们之前观察到在从墨西哥患者中分离的 BRCA 样本中,miR-650 的扩增(Amp-650)与 EMT 特征之间存在相关性。在这项研究中,我们探索了 cBioportal 数据库,旨在扩展该观察结果,并更好地理解 Amp-650 对 BRCA 侵袭性的重要性。我们发现 Amp-650 在 BRCA 的侵袭性分子亚型中更为常见,以及在高级低分化肿瘤中更为常见,我们在外部 miRNA 表达数据库中证实了这一点。我们对携带 Amp-650 的样本进行了差异表达分析,利用基因靶标预测工具和肿瘤抑制基因数据库挖掘了数百个差异表达下调的基因。我们观察到 STAT5A 可能是 BRCA 中侵袭性低分化 miR-650 的一个潜在靶基因。与具有 Amp-650 和低表达 STAT5A 的样本相比,具有任一或均无这些改变的样本的总生存期更短。BRCA 中尚未描述 miR-650 的靶基因,因此,这项生物信息学研究提供了有价值的信息,应通过实验加以证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/3a4ba90120a5/ijms-21-07720-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/12a20eb0baa1/ijms-21-07720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/2f1ed19e9b18/ijms-21-07720-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/11482ff91f8d/ijms-21-07720-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/22ab74ae4829/ijms-21-07720-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/3a4ba90120a5/ijms-21-07720-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/12a20eb0baa1/ijms-21-07720-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/2f1ed19e9b18/ijms-21-07720-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/11482ff91f8d/ijms-21-07720-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/22ab74ae4829/ijms-21-07720-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3691/7589888/3a4ba90120a5/ijms-21-07720-g005.jpg

相似文献

1
A Bioinformatic Pipeline Places STAT5A as a miR-650 Target in Poorly Differentiated Aggressive Breast Cancer.生物信息学分析提示 STAT5A 是低分化侵袭性乳腺癌中 miR-650 的靶基因。
Int J Mol Sci. 2020 Oct 19;21(20):7720. doi: 10.3390/ijms21207720.
2
miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions.miR-223 通过生物信息学预测揭示了其作为乳腺癌进展协调因子的作用。
PLoS One. 2014 Jan 6;9(1):e84859. doi: 10.1371/journal.pone.0084859. eCollection 2014.
3
miR-221/222 control luminal breast cancer tumor progression by regulating different targets.微小RNA-221/222通过调控不同靶点来控制腔面型乳腺癌的肿瘤进展。
Cell Cycle. 2014;13(11):1811-26. doi: 10.4161/cc.28758. Epub 2014 Apr 15.
4
Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.miR-8084 通过增强增殖、抑制凋亡和诱导上皮-间充质转化促进乳腺癌的发生。
J Transl Med. 2018 Feb 23;16(1):38. doi: 10.1186/s12967-018-1419-5.
5
Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.孕酮对miR-141的下调作用通过维持孕酮受体和Stat5a促进了乳腺癌干细胞样细胞的扩增。
Oncogene. 2015 Jul;34(28):3676-87. doi: 10.1038/onc.2014.298. Epub 2014 Sep 22.
6
MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.微小RNA-9与乳腺癌中的上皮-间质转化、乳腺癌干细胞表型及肿瘤进展相关。
Breast Cancer Res Treat. 2014 Aug;147(1):39-49. doi: 10.1007/s10549-014-3069-5. Epub 2014 Aug 3.
7
Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.微小RNA(miR)203、887、3619和182的下调可预防波形蛋白触发的、磷脂酶D(PLD)介导的癌细胞侵袭。
J Biol Chem. 2016 Jan 8;291(2):719-30. doi: 10.1074/jbc.M115.686006. Epub 2015 Nov 15.
8
HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth.组蛋白去乙酰化酶6使高迁移率族蛋白N2去乙酰化以调节信号转导和转录激活因子5a活性及乳腺癌生长。
Mol Cancer Res. 2016 Oct;14(10):994-1008. doi: 10.1158/1541-7786.MCR-16-0109. Epub 2016 Jun 29.
9
Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.丝氨酸残基 726 和 780 在腔面乳腺癌中具有调控 STAT5a 活性的非冗余作用。
Sci Rep. 2021 Jun 29;11(1):13506. doi: 10.1038/s41598-021-92830-8.
10
miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.miR-665 表达通过靶向 NR4A3 预测乳腺癌不良预后并促进肿瘤转移。
Cell Death Dis. 2019 Jun 17;10(7):479. doi: 10.1038/s41419-019-1705-z.

引用本文的文献

1
miR-1247-3p targets STAT5A to inhibit lung adenocarcinoma cell migration and chemotherapy resistance.微小RNA-1247-3p靶向信号转导和转录激活因子5A以抑制肺腺癌细胞迁移和化疗耐药性。
J Cancer. 2022 Mar 28;13(7):2040-2049. doi: 10.7150/jca.65167. eCollection 2022.

本文引用的文献

1
The Promising Role of miR-21 as a Cancer Biomarker and Its Importance in RNA-Based Therapeutics.miR-21作为癌症生物标志物的潜在作用及其在基于RNA的治疗中的重要性。
Mol Ther Nucleic Acids. 2020 Jun 5;20:409-420. doi: 10.1016/j.omtn.2020.03.003. Epub 2020 Mar 13.
2
Oncogenic microRNA-765 promotes the growth and metastasis of breast carcinoma by directly targeting ING4.致癌性微小RNA-765通过直接靶向ING4促进乳腺癌的生长和转移。
J Cell Biochem. 2020 Aug;121(8-9):3887-3900. doi: 10.1002/jcb.29545. Epub 2019 Nov 13.
3
Prognostic Factors for Luminal B-like Breast Cancer.
腔面 B 型乳腺癌的预后因素。
Curr Med Sci. 2019 Jun;39(3):396-402. doi: 10.1007/s11596-019-2049-8. Epub 2019 Jun 17.
4
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.miR-650 通过靶向 PPP2CA 促进间变性甲状腺癌细胞的迁移。
Endocrine. 2019 Sep;65(3):582-594. doi: 10.1007/s12020-019-01910-3. Epub 2019 Mar 29.
5
The essential role of tumor suppressor gene in various human cancers and non-neoplastic disorders.肿瘤抑制基因在各种人类癌症和非肿瘤性疾病中的重要作用。
Biosci Rep. 2019 Jan 30;39(1). doi: 10.1042/BSR20180773. Print 2019 Jan 31.
6
miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.miR-650通过直接抑制LATS2表达促进肝细胞癌的转移和上皮-间质转化。
Cell Physiol Biochem. 2018;51(3):1179-1192. doi: 10.1159/000495495. Epub 2018 Nov 27.
7
STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets.STRING v11:具有增强覆盖范围的蛋白质-蛋白质相互作用网络,支持在全基因组实验数据集的功能发现。
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613. doi: 10.1093/nar/gky1131.
8
Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer.miR-342-3p 功能丧失导致 MCT1 过表达,并促进三阴性乳腺癌的致癌代谢重编程。
Sci Rep. 2018 Aug 16;8(1):12252. doi: 10.1038/s41598-018-29708-9.
9
Loss of Nuclear Localized Parathyroid Hormone-Related Protein in Primary Breast Cancer Predicts Poor Clinical Outcome and Correlates with Suppressed Stat5 Signaling.原发性乳腺癌中核定位的甲状旁腺激素相关蛋白丢失预示着不良的临床结局,并与受抑制的 Stat5 信号相关。
Clin Cancer Res. 2018 Dec 15;24(24):6355-6366. doi: 10.1158/1078-0432.CCR-17-3280. Epub 2018 Aug 10.
10
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities.癌症中的上皮-间充质转化:复杂性和机遇。
Front Med. 2018 Aug;12(4):361-373. doi: 10.1007/s11684-018-0656-6. Epub 2018 Jul 24.